Maghemite/poly(D,L-lactide-co-glycolyde) composite nanoplatform for therapeutic applications

Journal of Nanoparticle Research

Volumn 14, Issue 4, 2012, Pages

  Pérez Artacho, Beatriz ^a   Gallardo, Visitación ^a   Ruiz, M Adolfina ^a   Arias, José L ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

Biodegradable nanocomposite; Hyperthermia; Maghemite; Magnetic drug targeting; Multifunctional nanoparticle; Poly(DL lactide co glycolide)

Indexed keywords

BLOOD; EMULSIFICATION; IONIC STRENGTH; NANOCOMPOSITES; NANOPARTICLES; PHYSICAL CHEMISTRY; SYNTHESIS (CHEMICAL); TARGETED DRUG DELIVERY; THERMOANALYSIS;

BIODEGRADABLE NANOCOMPOSITES; HYPERTHERMIA; MAGHEMITES; MAGNETIC DRUG TARGETING; MULTI-FUNCTIONAL NANOPARTICLES; POLY(DL-LACTIDE-COGLYCOLIDE);

NANOMAGNETICS;

COPOLYMER; FERRIC OXIDE; NANOPARTICLE; POLYGLACTIN; SOLVENT;

ADULT; ARTICLE; BLOOD COMPATIBILITY; DRUG DELIVERY SYSTEM; EMULSION; EVAPORATION; FEMALE; HEATING; HUMAN; HYDROPHOBICITY; IN VITRO STUDY; MAGNETIC FIELD; MAGNETISM; NORMAL HUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SURFACE PROPERTY; TEMPERATURE; THERMODYNAMICS;

EID: 84857681423     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-012-0768-x     Document Type: Article

References (44)

1. Arias JL (2011) Drug targeting strategies in cancer treatment: an overview. Mini Rev Med Chem 11:1-17. doi:10.2174/138955711793564024
2. Arias JL, López-Viota M, Ruiz MA, López-Viota J, Delgado AV (2007) Development of carbonyl iron/ethylcellulose core/shell nanoparticles for biomedical applications. Int J Pharm 339:237-245. doi:10.1016/j.ijpharm.2007. 02.028 (Pubitemid 46977602)
3. Arias JL, Reddy LH, Couvreur P (2008) Magnetoresponsive squalenoyl gemcitabine composite nanoparticles for cancer active targeting. Langmuir 24:7512-7519. doi:10.1021/la800547s
4. Arias JL, Gómez-Gallo A, Delgado AV, Gallardo V (2009) Study of the stability of Kollidon-SR for pharmaceutical applications. Colloids Surf A Physicochem Eng Aspects 338:107-113. doi:10.1016/j.colsurfa.2009.01.001
5. Arias JL, Martínez-Soler GI, López-Viota M, Ruiz MA (2010) Formulation of chitosan nanoparticles loaded with metronidazole for the treatment of infectious diseases. Lett Drug Des Discov 7:70-78. doi:10.2174/157018010790225831
6. Arias JL, Reddy LH, Othman M, Gillet B, Desmaële D, Zouhiri F, Dosio F, Gref R, Couvreur P (2011a) Squalene based nanocomposites: a new platform for the design of multifunctional pharmaceutical theragnostics. ACS Nano 5:1513-1521. doi:10.1021/nn1034197
7. Arias JL, López-Viota M, Sáez-Fernández E, Ruiz MA, Delgado AV (2011b) Engineering of an antitumor (core/shell) magnetic nanoformulation based on the chemotherapy agent ftorafur. Colloids Surf A Physicochem Eng Aspects 384:157-163. doi:10.1016/j.colsurfa.2011.03.051
8. Babincov M, Altanerov V, Altaner C, Bergemann C, Babinec P (2008) In vitro analysis of cisplatin functionalized magnetic nanoparticles in combined cancer chemotherapy and electromagnetic hyperthermia. IEEE Trans Nanobiosci 7:15-19. doi:10.1109/TNB.2008.2000145
9. Bee A, Massart R, Neveu S (1995) Synthesis of very fine maghemite particles. J Magn Magn Mater 149:6-9. doi: 10.1016/0304-8853(95)00317-7
10. Campbell RB (2007) Battling tumors with magnetic nanotherapeutics and hyperthermia: turning up the heat. Nanomed 2:649-652. doi:10.2217/17435889.2.5. 649 (Pubitemid 350268244)
11. Cózar-Bernal MJ, Holgado MA, Arias JL, Muñoz-Rubio I, Mart?n-Banderas L, Álvarez-Fuentes J, Fernández-Arévalo M (2011) Insulin-loaded PLGA microparticles: flow focusing versus double emulsion/solvent evaporation. J Microencapsul 28:430-441. doi:10(3109/02652048), 2011,576786
12. Dash BC, Réthoré G, Monaghan M, Fitzgerald K, Gallagher W, Pandit A (2010) The influence of size and charge of chitosan/ polyglutamic acid hollow spheres on cellular internalization, viability and blood compatibility. Biomaterials 31:8197-8818. doi:10.1016/j.biomaterials.2010.07.067
13. Depeyrot J, Sousa EC, Aquino R, Tourinho FA, Dubois E, Bacri JC, Perzynski R (2002) Rare earth doped maghemite EDLMF: a perspective for nanoradiotherapy? J Magn Magn Mater 252:375-377. doi:10.1016/S0304-8853(02) 00623-6
14. Fang C, Zhang M (2010) Nanoparticle-based theragnostics: integrating diagnostic and therapeutic potentials in nanomedicine. J Control Release 146:2-5. doi:10.1016/j.jconrel.2010.05.013
15. Gonzales M, Krishnan KM (2005) Synthesis of magnetoliposomes with monodisperse iron oxide nanocrystal cores for hyperthermia. J Magn Magn Mater 293:265-270. doi: 10.1016/j.jmmm.2005.02.020 (Pubitemid 40608936)
16. Holgado MA, Cózar-Bernal MJ, Salas S, Arias JL, Alvarez-Fuentes J, Fernández-Arévalo M (2009) Protein-loaded PLGA microparticles engineered by flow focusing: physicochemical characterization and protein detection by reversed-phase HPLC. Int J Pharm 380:147-154. doi: 10.1016/j.ijpharm.2009.07.017
17. HolgadoMA,Alvarez-Fuentes J, Fernández-ArévaloM, Arias JL (2011) Possibilities of poly(D,L-lactide-co-glycolide) in the formulation of nanomedicines against cancer. Curr Drug Targets 12:1096-1111. doi:10.2174/138945011795906606
18. Huber DL (2005) Synthesis, properties, and applications of iron nanoparticles. Small 1:482-501. doi:10.1002/smll.200500 006 (Pubitemid 43951747)
19. Janib SM, Moses AS, MacKay JA (2010) Imaging and drug delivery using theranostic nanoparticles. Adv Drug Deliv Rev 62:1052-1063. doi:10.1016/j.addr. 2010.08.004
20. Jordan A, Scholz R, Maier-Hauff K, Johannsen M, Wust P, Nadobny J, Schirra H, Schmidt H, Deger S, Loening S, Lanksch W, Felix R (2001) Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia. J Magn Magn Mater 225:118-126. doi:10.1016/S0304-8853(00)01239-7 (Pubitemid 32335284)
21. Kalele S, Narain R, Krishnan KM (2009) Probing temperaturesensitive behavior of pNIPAAm-coated iron oxide nanoparticles using frequency-dependent magnetic measurements. J Magn Magn Mater 321:1377-1380. doi:10.1016/j.jmmm.2009. 02.134
22. Kievit FM, Veiseh O, Bhattarai N, Fang C, Gunn JW, Lee D, Ellenbogen RG, Olson JM, Zhang M (2009) PEI-PEGchitosan copolymer coated iron oxide nanoparticles for safe gene delivery: synthesis, complexation, and transfection. Adv Funct Mater 19:2244-2251. doi:10.1002/adfm.200801844
23. Kumagai M, Imai Y, Nakamura T, Yamasaki Y, Sekino M, Ueno S, Hanaoka K, Kikuchi K, Nagano T, Kaneko E, Shimokado K, Kataoka K (2007) Iron hydroxide nanoparticles coated with poly(ethylene glycol)-poly(aspartic acid) block copolymer as novel magnetic resonance contrast agents for in vivo cancer imaging. Colloids Surf B Biointerfaces 56:174-181. doi:10.1016/j.colsurfb.2006. 12.019 (Pubitemid 46467334)
24. Lammers T, Kiessling F, Hennink WE, Storm G (2010) Nanotheranostics and image-guided drug delivery: current concepts and future directions. Mol Pharm 7:1899-1912.doi:10.1021/mp100228v
25. Lao LL, Ramanujan RV (2004) Magnetic and hydrogel composite materials for hyperthermia applications. J Mater Sci: Mater Med 15:1061-1064. doi:10.1023/B:JMSM.00000 46386.78633.e5 (Pubitemid 39491711)
26. Laurent S, Forge D, Port M, Roch A, Robic C, Elst LV, Muller RN (2008) Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 108:2064-2110. doi:10.1021/cr068445e
27. Lyklema J (2002) The role of surface conduction in the development of electrokinetics. In: Delgado AV (ed) Interfacial electrokinetics and electrophoresis. Marcel Dekker, New York, pp 87-98
28. Lyon RJP (1967) Infrared absorption spectroscopy. In: Zussman J (ed) Physical methods in determinative mineralogy. Academic Press, London and New York, pp 371-399
29. Massart R (1981) Preparation of aqueous magnetic liquids in alkaline and acidic media. IEEE Trans Magn 17:1247-1248. doi:10.1109/TMAG.1981.1061188 (Pubitemid 11497282)
30. Musumeci T, Ventura CA, Giannone I, Ruozi B, Montenegro L, Pignatello R, Puglisi G (2006) PLA/PLGA nanoparticles for sustained release of docetaxel. Int J Pharm 325:172-179. doi:10.1016/j.ijpharm.2006.06.023 (Pubitemid 44573694)
31. O'Brien RW, White LR (1978) Electrophoretic mobility of a spherical colloidal particle. J Chem Soc Faraday Trans 2:1607-1626. doi:10.1039/ F29787401607
32. Okassa LN, Marchais H, Douziech-Eyrolles L, Hervé K, Cohen- Jonathan S, Munnier E, Soucé M, Linassier C, Dubois P, Chourpa I (2007) Optimization of iron oxide nanoparticles encapsulation within poly(D,L-lactide-co-glycolide) submicron particles. Eur J Pharm Biopharm 67:31-38. doi: 10.1016/j.ejpb.2006.12.020 (Pubitemid 46991326)
33. Plaza RC, Arias JL, Espín M, Jiménez ML, Delgado AV (2002) Aging effects in the electrokinetics of colloidal iron oxides. JColloid Interface Sci 245:86-90. doi:10.1006/jcis.2001.7964 (Pubitemid 34953370)
34. Purushotham S, Ramanujan RV (2010) Thermoresponsive magnetic composite nanomaterials for multimodal cancer therapy. Acta Biomater 6:502-510. doi:10.1016/j.actbio.2009.07.004
35. Santos JG, Silveira LB, Oliveira AC, Garg VK, Lacava BM, Tedesco AC, Morais PC (2007) Mössbauer investigation of maghemite-based glycolic acid nanocomposite. Hyperfine Interact 175:71-75. doi:10.1007/s10751-008-9590-3
36. Schellenberger E, Schnorr J, Reutelingsperger C, Ungethüm L, Meyer W, Taupitz M, Hamm B (2008) Linking proteins and anionic nanoparticles via protamine: ultrasmall protein-coupled probes for magnetic resonance imaging of apoptosis. Small 4:225-230. doi:10.1002/smll.200700847 (Pubitemid 351271155)
37. Shubayev VI, Pisanic TR II, Jin S (2009) Magnetic nanoparticles for theragnostics. Adv Drug Deliv Rev 61:467-477. doi:10.1016/j.addr.2009.03.007
38. Takamatsu S, Matsui O, Gabata T, Kobayashi S, Okuda M, Ougi T, Ikehata Y, Nagano I, Nagae H (2008) Selective induction hyperthermia following transcatheter arterial embolization with a mixture of nano-sized magnetic particles (ferucarbotran) and embolic materials: feasibility study in rabbits. Radiat Med 26:179-187. doi:10.1007/s11604-007-0212-9 (Pubitemid 351754720)
39. Tashjian JA, Dewhirst MW, Needham D, Viglianti BL (2008) Rationale for and measurement of liposomal drug delivery with hyperthermia using non-invasive imaging techniques. Int J Hyperthermia 24:79-90. doi:10.1080/02656730701840147 (Pubitemid 351167621)
40. Terreno E, Castelli DD, Viale A, Aime S (2010) Challenges for molecular magnetic resonance imaging. Chem Rev 110:3019-3042. doi:10.1021/cr100025t
41. van Oss CJ (2006) Interfacial forces in aqueous media, 2nd edn. CRC Press, Boca Raton
42. Weissleder R, Bogdanov A, Neuwelt EA, Papisov M(1995) Longcirculating iron oxides for MR imaging. Adv Drug Deliv Rev 16:321-334. doi:10.1016/0169- 409X(95)00033-4
43. Xie J, Chen K, Huang J, Lee S, Wang J, Gao J, Li X, Chen X (2010) PET/NIRF/MRI triple functional iron oxide nanoparticles. Biomaterials 31:3016-3022. doi:10.1016/j.biomaterials.2010.01.010
44. Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC (2008) Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther 83: 761-769. doi:10.1038/sj.clpt.6100400 (Pubitemid 351556021)